Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-05-01 Sale |
2024-05-03 5:16 pm |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
29,206 | $14.02 | $409,426 | 3,406,335 (Indirect) |
View |
2024-04-24 Sale |
2024-04-26 5:01 pm |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
1,781 | $14.06 | $25,041 | 3,435,541 (Indirect) |
View |
2024-04-19 Sale |
2024-04-23 6:38 pm |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
64,653 | $14.12 | $913,057 | 3,437,322 (Indirect) |
View |
2024-04-16 Sale |
2024-04-18 5:10 pm |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
16,992 | $14.02 | $238,231 | 3,501,975 (Indirect) |
View |
2024-04-11 Sale |
2024-04-15 5:25 pm |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
485,000 | $14.49 | $7,026,033 | 3,518,967 (Indirect) |
View |
2024-02-02 Sale |
2024-02-06 7:16 pm |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
17,589 | $15.09 | $265,401 | 77,762 (Direct) |
View |
2024-01-30 Sale |
2024-02-01 9:47 pm |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
13,848 | $15.09 | $208,965 | 95,351 (Direct) |
View |
2024-01-24 Sale |
2024-01-26 6:04 pm |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
828 | $15.02 | $12,441 | 109,199 (Direct) |
View |
2023-12-26 Sale |
2023-12-28 5:47 pm |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
13,402 | $10.12 | $135,668 | 110,027 (Direct) |
View |
2023-12-20 Sale |
2023-12-22 4:21 pm |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
2,730 | $10.14 | $27,695 | 123,429 (Direct) |
View |
2023-12-06 Sale |
2023-12-07 4:07 pm |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
11,005 | $8.1575 | $89,773 | 126,159 (Direct) |
View |
2023-11-29 Sale |
2023-12-01 9:57 pm |
NeuroPace Inc | NPCE | KCK LTD. 10% Owner |
16,167 | $8.7761 | $141,882 | 5,593,773 (Direct) |
View |
2023-11-27 Sale |
2023-11-29 5:35 pm |
NeuroPace Inc | NPCE | KCK LTD. 10% Owner |
11,171 | $8.872 | $99,109 | 5,609,940 (Direct) |
View |
2023-10-02 Sale |
2023-10-04 5:36 pm |
NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
8,314 | $9.0749 | $75,449 | 4,003,967 (Indirect) |
View |
2022-11-21 Purchase |
2022-11-23 5:29 pm |
NeuroPace Inc | NPCE | Accelmed Partners II L.P. 10% Owner |
390,291 | $1.499 | $585,046 | 4,432,948 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-07 Option Award |
2024-06-11 4:17 pm |
N/A 2034-06-06 |
NeuroPace Inc | NPCE | Kumar Rakhi Director |
17,774 | $0 | 17,774 (Direct) |
View |
2024-06-07 Option Award |
2024-06-11 4:16 pm |
N/A 2034-06-06 |
NeuroPace Inc | NPCE | Fischer Frank M Director |
17,774 | $0 | 17,774 (Direct) |
View |
2024-06-07 Option Award |
2024-06-11 4:15 pm |
N/A 2034-06-06 |
NeuroPace Inc | NPCE | Geiger Uri Director |
17,774 | $0 | 17,774 (Direct) |
View |
2024-06-07 Option Award |
2024-06-11 4:14 pm |
N/A 2034-06-06 |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
17,774 | $0 | 17,774 (Direct) |
View |
2024-02-27 Option Award |
2024-02-28 8:56 pm |
N/A 2034-02-26 |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
37,450 | $0 | 115,212 (Direct) |
View |
2024-02-27 Option Award |
2024-02-28 8:54 pm |
N/A 2034-02-26 |
NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer |
37,450 | $0 | 177,154 (Direct) |
View |
2024-02-27 Option Award |
2024-02-28 8:52 pm |
N/A 2034-02-26 |
NeuroPace Inc | NPCE | Becker Joel Chief Executive Officer |
157,190 | $0 | 157,190 (Direct) |
View |
2023-07-18 Option Award |
2023-07-19 4:47 pm |
N/A 2033-07-17 |
NeuroPace Inc | NPCE | Becker Joel Chief Executive Officer |
380,424 | $0 | 380,424 (Direct) |
View |
2023-06-07 Option Award |
2023-06-14 5:00 pm |
N/A 2033-06-06 |
NeuroPace Inc | NPCE | Andrade Lisa Director |
27,380 | $0 | 27,380 (Direct) |
View |
2023-06-07 Option Award |
2023-06-14 4:59 pm |
N/A 2033-06-06 |
NeuroPace Inc | NPCE | Fischer Frank M Director |
27,380 | $0 | 27,380 (Direct) |
View |
2023-06-07 Option Award |
2023-06-14 4:58 pm |
N/A 2033-06-06 |
NeuroPace Inc | NPCE | Geiger Uri Director |
27,380 | $0 | 27,380 (Direct) |
View |
2023-06-07 Option Award |
2023-06-14 4:56 pm |
N/A 2033-06-06 |
NeuroPace Inc | NPCE | Kumar Rakhi Director |
27,380 | $0 | 27,380 (Direct) |
View |
2023-06-07 Option Award |
2023-06-14 4:54 pm |
N/A 2033-06-06 |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
27,380 | $0 | 27,380 (Direct) |
View |
2023-06-07 Option Award |
2023-06-14 4:53 pm |
N/A 2033-06-06 |
NeuroPace Inc | NPCE | Ryan Renee Director |
27,380 | $0 | 27,380 (Direct) |
View |
2023-02-20 Option Award |
2023-02-22 7:54 pm |
N/A N/A |
NeuroPace Inc | NPCE | Ridley Irina Chief Legal Officer/Secretary |
80,000 | $0 | 141,139 (Direct) |
View |
2023-02-20 Option Award |
2023-02-22 7:53 pm |
N/A N/A |
NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer |
80,000 | $0 | 139,704 (Direct) |
View |
2023-02-20 Option Award |
2023-02-22 7:39 pm |
N/A N/A |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
80,000 | $0 | 137,164 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 7:38 pm |
N/A N/A |
NeuroPace Inc | NPCE | Favet Michael Chief Executive Officer |
225,000 | $0 | 407,080 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:30 pm |
N/A 2033-01-04 |
NeuroPace Inc | NPCE | Geiger Uri Director |
120,521 | $0 | 120,521 (Direct) |
View |
Ownership |
2023-01-09 4:28 pm |
N/A N/A |
NeuroPace Inc | NPCE | Geiger Uri Director |
0 | $0 | 4,432,948 (Indirect) |
View |
2022-10-31 Exercise |
2022-11-02 9:18 pm |
N/A 2022-11-12 |
NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer |
1,428 | $0 | 59,704 (Direct) |
View |
2022-10-31 Exercise |
2022-11-02 9:18 pm |
N/A N/A |
NeuroPace Inc | NPCE | Kuhn Rebecca Chief Financial Officer |
1,428 | $0.026 | 59,704 (Direct) |
View |
2022-10-18 Exercise |
2022-10-20 7:57 pm |
N/A 2022-11-12 |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
192 | $0 | 352,112 (Direct) |
View |
2022-10-18 Exercise |
2022-10-20 7:57 pm |
N/A N/A |
NeuroPace Inc | NPCE | LACOB JOSEPH Director |
192 | $0.026 | 352,112 (Direct) |
View |
2022-10-07 Exercise |
2022-10-11 4:09 pm |
N/A 2022-11-13 |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
576 | $0 | 57,164 (Direct) |
View |
2022-10-07 Exercise |
2022-10-11 4:09 pm |
N/A N/A |
NeuroPace Inc | NPCE | Morrell Martha Chief Medical Officer |
576 | $0.026 | 57,164 (Direct) |
View |
2022-06-13 Option Award |
2022-06-21 9:13 pm |
N/A 2032-06-12 |
NeuroPace Inc | NPCE | Andrade Lisa Director |
18,253 | $0 | 18,253 (Direct) |
View |